Engaging with the Private Sector for Noncommunicable Disease Prevention and Control: Is it Possible to Create "Shared Value?"

Autor:	Collins TE; Global NCD Platform, World Health Organization, CH., Akselrod S; Global NCD Platform, World Health Organization, CH., Mahy L; Multisectoral Action in Food Systems, World Health Organization, CH., Poznyak V; Alcohol, Drugs and Addictive Behaviors, World Health Organization, CH., Berlina D; Global NCD Platform, World Health Organization, CH., Hatefi A; University of California San Francisco, USA., Allen L; Global NCD Platform, World Health Organization, CH.
Jazyk:	angličtina
Zdroj:	Annals of global health [Ann Glob Health] 2023 Jul 03; Vol. 89 (1), pp. 46. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023).
DOI:	10.5334/aogh.4136
Abstrakt:	Noncommunicable diseases (NCDs) are the leading cause of premature mortality worldwide. Corporate interests are sometimes well-aligned with public health, but profiteering from the consumption of products that are known to be the major contributors to the noncommunicable disease burden undermines public health. This paper describes the key industry actors shaping the NCD landscape; highlights the unhealthy commodities' impact on health and the growing burden of NCDs; and outlines challenges and opportunities to reduce exposure to those risk factors. Corporations deploy a wide array of strategies to maximize profits at the expense of health, including sophisticated marketing techniques, interference in the policy-making process, opposition and distortion of research and evidence, and whitewashing of health-harming activities through corporate social responsibility initiatives. There can be no shared value for industries that sell goods that harm health irrespective of consumption patterns (such as tobacco and likely alcohol), so government actions such as regulation and legislation are the only viable policy instruments. Where shared value is possible (for example, with the food industry), industry engagement can potentially realign corporate interests with the public health interest for mutual benefit. Deliberate, careful, and nuanced approaches to engagement are required. Competing Interests: The authors have no competing interests to declare. (Copyright: © 2023 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu